tiprankstipranks
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market
XBIO
Xenetic Biosciences
RESEARCH TOOLSreports

Xenetic Biosciences (XBIO) Income Statement

340 Followers

Xenetic Biosciences Income Statement

Last quarter (Q4 2025), Xenetic Biosciences's total revenue was $766.30K, an increase of 18.11% from the same quarter last year. In Q4, Xenetic Biosciences's net income was $-579.08K. See Xenetic Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.98M$ 2.50M$ 2.54M$ 1.71M$ 1.16M
Gross Profit
$ 2.98M$ 2.50M$ 2.54M$ 1.71M$ 1.16M
Operating Expenses
$ 5.81M$ 6.70M$ 7.06M$ 8.42M$ 6.91M
Depreciation and Amortization
$ 0.00$ 153.34K$ 0.00$ 27.04K$ 35.48K
EBITDA
$ -2.83M$ -4.05M$ -4.52M$ -6.69M$ -5.71M
Operating Income
$ -2.83M$ -4.20M$ -4.52M$ -6.72M$ -5.75M
Other Income/Expenses
$ 153.72K$ 244.15K$ 381.14K$ 165.56K$ 101.59K
Pretax Income
$ -2.68M$ -3.96M$ -4.13M$ -6.55M$ -5.65M
Net Income
$ -2.68M$ -3.96M$ -4.13M$ -6.55M$ -5.65M
Per Share Metrics
Basic EPS
$ -1.58$ -2.57$ -2.71$ -4.49$ -5.39
Diluted EPS
$ -1.58$ -2.57$ -2.71$ -4.49$ -5.39
Weighted Average Shares Outstanding
 1.70M 1.54M 1.53M 1.42M 1.03M
Weighted Average Shares Outstanding (Diluted)
 1.70M 1.54M 1.53M 1.42M 1.03M
Currency in USD

Xenetic Biosciences Earnings and Revenue History